LinkedIn View on LinkedIn
Simon Ducharme is Co- Founder of AFX Medical. Dr. Ducharme has a medical degree from the Université de Montréal and a Masters from McGill University. He completed his residency in Psychiatry at McGill in 2012, and a fellowship in Behavioral Neurology & Neuropsychiatry at Harvard University in 2014. He is a Neuropsychiatrist at the Montreal
Neurological Institute/MUHC and an associate professor in the Department of Psychiatry. Dr. Ducharme holds a junior 2 clinician-scientist award. His research uses advanced structural brain imaging techniques to study the longitudinal changes in brain development from childhood to old age, and how it impacts behavior across health and psychopathology. His current projects aim to develop novel neuroimaging diagnostic and prognostic biomarkers for frontotemporal dementia. Dr. Ducharme is the author of more than 60 peer-reviewed articles and 7 book chapters. Since the beginning of his medical training, Dr. Ducharme has received over 35 awards of academic or research excellence, including the 2013 Career Development Award from the American Neuropsychiatric Association. His is currently the chair of the American Neuropsychiatric Association committee on research. He is the Montreal site PI of the Genetic Frontotemporal Dementia Initiative study and the director of the FTD team of the Canadian Consortium on Neurodegeneration in Aging. He is the research director of the McGill University Health Centre Mental Health Mission. He is in charge of several clinical trials in dementia at the MNI. In April 2018 he co-founded AFX Medical, a start-up providing AI solutions for brain imaging.
